The COVID-19 vaccine continues to save lives, proving the vaccination strategy paid off and was a worthwhile national ...

Officials say the Army has reenlisted more than 23 soldiers who were discharged for refusing the COVID-19 vaccine.

Pfizer faces growth challenges with patent losses and waning COVID sales. Selling an ATM Put option expiring Nov'25 could ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

A passion for learning took her from apartheid South Africa to a beer brewery to becoming a healthcare consultant, all before ...

Five years ago, volunteers rolled up their sleeves in the first clinical trial of a vaccine against COVID-19, as the new ...

PFE stock is likely to be a great pick for value investors, considering its cheap valuation, as well as for income investors ...

As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...

Shares of Novavax (NVAX) are under pressure on Thursday following Robert F. Kennedy Jr.’s comments on the company’s COVID shot approval delay.

Novavax uses protein-based technology, a more traditional method than the mRNA vaccines from Pfizer and Moderna ... showed our vaccine is safe and effective for the prevention of COVID-19.” “We are ...

The Kansas Supreme Court is weighing whether to block a sweeping state law that lets workers easily bypass COVID-19 vaccine ...